Arterial disease, also known as atherosclerosis, is a condition of astonishing lethality. Alone, it’s responsible for approximately 50 percent of all deaths in the developed world. The odds are sadly high that all of us know someone who has been diagnosed with this malady.However, if diagnosed and treated early, lives can be saved. At Sotere Medical Solutions, we are committed to diagnosing and recognizing the possibility of atherosclerosis in patients. We accomplished this by creating the Sotere Cardiac Platform, a revolutionary heart medical device that detects heart disease, specifically arterial disease.
The Sotere Cardiac Platform is a noninvasive procedure designed to identify signs of early onset atherosclerosis that are missed by most clinical tests. With 97 percent accuracy, this process is fast, convenient, and can reduce healthcare costs while increasing life quality and health. There isn’t any other device on the market that is able to test for atherosclerosis this accurately.
Product innovator and developer, Dr. Jeffrey K Raines, teamed with CEO David A. Bonk, CFO Leigh Caldwell, Director of Sales Kerry Van Isegham. With more than 100 years of combined experience, the team has healthcare and business backgrounds from Harvard, MIT, The University of Buffalo, University of Rochester and RIT and we are participating members in good standing with:
Learn more about the Sotere Cardiac Platform